HemaSphere
(Jun 2022)
P1080: COMPARISON OF NIVOLUMAB 40 MG EFFICACY VERSUS 3 MG/KG IN PATIENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA
- L. Fedorova,
- K. Lepik,
- N. Mikhailova,
- E. Kondakova,
- Y. Komarova,
- M. Popova,
- P. Kotselyabina,
- E. Borzenkova,
- V. Baykov,
- I. Moiseev,
- A. Kulagin
Affiliations
- L. Fedorova
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- K. Lepik
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- N. Mikhailova
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- E. Kondakova
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- Y. Komarova
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- M. Popova
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- P. Kotselyabina
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- E. Borzenkova
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- V. Baykov
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- I. Moiseev
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- A. Kulagin
- 1 RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
- DOI
-
https://doi.org/10.1097/01.HS9.0000847188.87255.f7
- Journal volume & issue
-
Vol. 6
pp.
970
– 971
WeChat QR code